Evernest Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Buy
4,640
+168
+4% +$172K 1.16% 20
2026
Q1
$3.88M Buy
4,472
+213
+5% +$216K 0.81% 23
2025
Q4
$4.45M Sell
4,259
-421
-9% -$403K 0.93% 24
2025
Q3
$3.57M Sell
4,680
-198
-4% -$147K 1% 23
2025
Q2
$3.8M Buy
4,878
+99
+2% +$76.9K 1.23% 20
2025
Q1
$3.95M Buy
4,779
+360
+8% +$300K 1.42% 19
2024
Q4
$3.41M Sell
4,419
-207
-4% -$171K 0.89% 24
2024
Q3
$4.1M Sell
4,626
-94
-2% -$84.5K 1.1% 20
2024
Q2
$4.27M Buy
4,720
+124
+3% +$99.2K 1.91% 16
2024
Q1
$3.34M Buy
4,596
+127
+3% +$90.4K 1.58% 17
2023
Q4
$2.61M Buy
+4,469
New +$2.61M 1.32% 17
2021
Q4
$3.32M Buy
+4,483
New +$1.14M 1.72% 17

Other funds holding LLY

Evernest Financial Advisors's LLY Position: Q2 2026 in Review

Evernest Financial Advisors increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $172K and bringing the position to 4,640 shares worth $5.56M. The position accounts for 1.16% of the portfolio, ranked #20.

Evernest Financial Advisors first reported a position in LLY in Q4 2021 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Evernest Financial Advisors held 4,640 shares of Eli Lilly worth $5.56M as of Q2 2026.
  • Evernest Financial Advisors bought 168 Eli Lilly shares in Q2 2026, an estimated $172K.
  • Eli Lilly made up 1.16% of Evernest Financial Advisors's portfolio in Q2 2026, its #20 holding.
  • Evernest Financial Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Evernest Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.